IL13RA2 and glioblastoma: A year later, the IL-13Rα2-CAR construct was updated to treat a 50-year-old male with recurrent and multifocal GBM.43 The patient received IL-13Rα2-CAR-T cells via intracavitary and intraventricular administration, for a total of 16 cycles.